1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsXcelerate RARE: Open Science Data Challenge is sponsored by Global Genes. A competitive environment where researchers collaborate to advance understanding of genetic variants across disorders.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Xcelerate-RARE-Open-Science-Data-Challenge - Global Genes Xcelerate RARE: Rare Disease Open Science Data Challenge The Xcelerate RARE: A Rare Disease Open Science Data Challenge brings together researchers and data scientists in a collaborative and competitive environment to make the best use of patient-provided data to solve big unknowns in healthcare.
The inaugural Open Science Data Challenge for researchers ran May 31 – August 31, 2023, and focused on rare pediatric neurodevelopmental diseases.
The goals of the Xcelerate RARE Open Science Data Challenge include: Shortening the diagnostic odyssey with predicted diagnosis Identifying previously unrecognized symptoms associated with some of these rare diseases Generating useful insights for advancing therapeutic research Congratulations to the Winners of the Inaugural Challenge!
The Inaugural Xcelerate RARE Open Science Data Challenge ran from May 31 – August 31, 2023, with 132 researchers from across the globe participating. This challenge gathered clinical researchers, data scientists, and biostatisticians in a collaborative and competitive environment to make the best use of patient-provided data to address significant challenges to research and medical management for patients with rare neurologic diseases.
It all starts with you and your de-identified health data from the Data Collection Program. The data collected in the program is openly available to researchers to advance therapeutic research. Academic Researchers & Data Scientists Xcelerate RARE offers your research team access to rare disease patient data and an opportunity for teams to work on important problems facing rare disease families in a fun, structured environment.
Researchers in Biotech / Pharma Companies The RARE-X dataset includes clinical diagnoses, detailed symptoms, curated genetic data, and patient-reported clinical outcome assessment measures (COAs) across 27 rare pediatric neurologic disorders. Data is patient-reported or provided, and patient-owned to provide open access to the research community.
Causative Rare Disease Variants (>50 Novel) Ultra-Rare Neurological Diseases Patients from 64 Countries Xcelerate RARE Challenge Tasks During the inaugural challenge, participants had the opportunity to address three tasks as part of the Open Science Data Challenge Identify underrecognized symptoms/ Expand definition of rare disease Dataset: De-identified US data on RARE-X platform; not downloadable # of Conditions covered: 27 Predict diagnosis based on symptoms, age of onset, disease severity, etc. Dataset: Synthetic data that mimics the format of training and validation data will be provided; downloadable # of Conditions covered: 16 In addition to the RARE-X data, this task will include: EHR data from 2 disease communities, curated by Ciitizen External registry data from 2 disease communities, provided by CoRDS Further or refute a therapeutic hypothesis in one or more rare disease Dataset: All RARE-X data accessed through our Data Analysis Platform on Terra, which includes de-identified US and ex-US data; not downloadable.
# of Conditions covered: 27 Collaboration with Industry Winning teams will have the opportunity to present their proposed solutions in front of Global Genes’ Research Advisory Council (leading pharma partners) to explore potential collaboration with industry.
Awards Ceremony & Recognition Winning teams will be publicly recognized at the RARE Advocacy Summit, one of the world’s largest gatherings of rare disease patients, caregivers, advocates, healthcare professionals, researchers, partners, and allies. For Task #3, related to therapeutic hypotheses, the RTW Charitable Foundation has agreed to “fast-track” the top 3 winning hypotheses to grant review.
Each of the 3 winning teams has the potential to be awarded a grant of up to $50,000 each. Are you a researcher interested in participating in the next Xcelerate RARE Open Science Data Challenge?
Researchers Register Here Thank You To Our Sponsors & Partners Founding Partner and Co-Organizer Planning Committee and Advisors Fanny Sie, MS – Head of Artificial Intelligence & Digital Health, Roche Mariam Ahmed, PMP, LSPO, CSM – Informatics Business Partner, Roche Ravi Bhargava, MD – AIDH Partner / Medical Director One Roche Global, Roche Joshua Hoang, MS – AI & Digital Healthcare Partner- Data Network Enablement, Roche Kristoph Klein-Panneton, MS – Integrated Evidence Generation Lead, Roche Ramanandan Prabhakaran- Roche Andrew Nguyen, PhD – Data Working Group Co-Chair, Section Head, Medical Informatics, AAIH, Roche Jennifer Tjernagel, MS – Senior Project Manager, Simons Foundation Joseph Geraci, PhD – Chief Scientific Officer, Netramark Anne O’Donnell-Luria, MD, PhD
According to the current listing, eligibility includes: Researchers in the rare disease field interested in open science data challenges. Confirm the full requirements in the official notice before applying.
Xcelerate RARE: Open Science Data Challenge is funded by Global Genes. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.